TPX2 and plasma cell myeloma: In addition, KIF4A overexpression can promote endometrial cancer progression by inhibiting TPX2 protein degradation [27], while KIF4A expression is reduced in gastric cancer, multiple myeloma, and acute myeloid leukemia [28].